Back to search

Aristotle University Of Thessaloniki (AUTH)

Ο ρόλος των ριβοενζύμων στην αποδόμηση του παθολογικού mRNA κολλαγόνου τύπου Ι στην ατελή οστεογένεση: πειραματική μελέτη

Abstract

dc:description

In the last decades the notion that all enzymes are proteins has changed. Small RNA molecules, the ribozymes, have catalytic properties. They can degrade complementary mRNA, carrying a mutation that is different compared to the normal form by only one base. In this way the expression of a mutated gene in a single gene disorder can be regulated. Ribozymes could be used in several conditions, such as in the case of viral infections. The aim of this thesis was to study the characteristics of the action of ribozymes in vitro and in cellulo and to produce a ribozyme that has greater intracellular stability and is therefore more effective. Osteogenesis imperfecta is a single gene systemic disease of the connective tissue and it involves type I collagen. The genes COL1A1 and COL1A2 are the two genes that code for type I collagen. And the majority of patients with osteogenesis imperfecta carry mutations in these two genes. We created a target based on the structure of COL1A1 and three point mutations were incorporated in this target to simulate the mutations that actually exist in osteogenesis imperfecta. Subsequently, ribozymes which target these three mutations were created. Multimers of these ribozymes were created that had the inherent ability to self-catalyse into monomers and to catalyse the target. Multiple trials of these ribozymes were carried out at different temperatures and molecular rates in vitro. Following that, cell lines that contained the target and one of the multimers were created. We also created a modified multimer that would catalyse the target without being self-catalysed into monomers. This modified multimer therefore sustains its large size and could potentially be more stable, not allowing cellular ribonucleases to degrade it and would therefore potentially be more effective in ablating the target. We performed trials to ascertain the half life of ribozymes and calculated the percent of the target ablated. In vitro experiments have shown that ribozymes achieve specific ablation of their target even if it differs from the normal at just one base. The homo-multimers and hetero-multimers of ribozymes retain their specificity of action just like monomers, while they also show increased catalytic action. In vitro trials showed that the hetero-multimers were indeed more effective than the homo-multimers as well as more than the prospective monoribozymes in the ablation of a target containing 3 mutations. These findings are encouraging as they mean that hetero-multimers can be used in systems with multiple targets, such as HIV or other viruses. An antivirus strategy that would utilize just one ribozyme would be destined to fail, as it is widely known that virus mutation rates are very high. The hetero-multimers would achieve long term effectiveness. In addition, in single gene disorders such as osteogenesis imperfecta some mutations are more frequent than others. Hetero-multimers targeting the most frequent mutations could be used as therapeutic agents in a great number of patients. In recent years a great effort has ensued in the designing of ribozymes with greater intracellular stability and potency. Ribozymes have been modified chemically and their molecular properties have been studied, in order to achieve a greater resilience against destruction from nucleases and an improvement of their catalytic activity. Thus, in this thesis as was mentioned before we constructed a modified multimer that could retain its large size. In the in vivo trials it was evident that this multimer could act intracellularly with the same specificity as the monomer. Additionally, it had a greater half life from the respective multimer which can catalyse itself into monomers and was eleven times more effective. The design of more stable and potent ribozymes could be based on the approach which was used in this thesis. In conclusion it could be said that it is of great importance that research in the field of ribozymes continues, in order to further understand the underlying mechanisms and improve the function of ribozymes which will inadvertedly show their important role in biology and medicine alike.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Λαδά, Ζωή

Subjects

dc:subject × 9

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19326

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Λαδά, Ζωή. Ο ρόλος των ριβοενζύμων στην αποδόμηση του παθολογικού mRNA κολλαγόνου τύπου Ι στην ατελή οστεογένεση: πειραματική μελέτη. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/19326